Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Calcifediol extended release - OPKO Renal/Vifor Fresenius Medical Care Renal Pharma

Drug Profile

Calcifediol extended release - OPKO Renal/Vifor Fresenius Medical Care Renal Pharma

Alternative Names: CTAP-101; CTAP101 Capsules; Modified-release calcifediol - OPKO Renal/Vifor Fresenius Medical Care Renal Pharma; RAYALDEE; Rayaldee; Rayaldy

Latest Information Update: 10 Oct 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cytochroma
  • Developer OPKO Renal; Vifor Fresenius Medical Care Renal Pharma
  • Class Calcium regulators; Osteoporosis therapies; Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Secondary hyperparathyroidism
  • Phase I Bone disorders

Most Recent Events

  • 07 Aug 2019 Preregistration for Secondary hyperparathyroidism in Switzerland (PO)
  • 07 Aug 2019 Vifor expects to receive approval in European countries to market Calcifediol extended release for Secondary hyperparathyroidism by 2020
  • 22 Jan 2019 OPKO Health completes a phase I trial in Healthy volunteers in USA (PO) (NCT03660800)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top